Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$119M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$100M |
| 3 |
3M
MMM
|
+$92.7M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$83.5M |
| 5 |
SHPG
Shire pic
SHPG
|
+$73.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$270M |
| 2 |
Microsoft
MSFT
|
+$195M |
| 3 |
UnitedHealth
UNH
|
+$192M |
| 4 |
Johnson & Johnson
JNJ
|
+$164M |
| 5 |
Apple
AAPL
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.64% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 12.06% |
| 4 | Communication Services | 9.18% |
| 5 | Consumer Discretionary | 7.38% |
Similar funds
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2018 Portfolio in Review
As of Q2 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 649 positions worth $14.1B, down 14% from $16.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.67B in Q2 2018, closing 99 positions and reducing 258 holdings. Its most notable exit was Monsanto Co, an estimated $270M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Shire pic worth $76.5M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2018 buy was Shire pic: 453,200 shares worth $76.5M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Visa in Q2 2018, an estimated $119M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2018 reduction was Microsoft, cutting an estimated $195M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Monsanto Co in Q2 2018, selling an estimated $270M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 31% of its $14.1B portfolio in Q2 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 82 new positions and closed 99 in Q2 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 14% quarter-over-quarter to $14.1B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2018, filed 14 Aug 2018.